Roald Van Der Laan - MGC-Department of Cell Biology and Genetics;Center for Biomedical Genetics;Department of Reproduction and Development;University Medical Center

基本信息

浏览量：18

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Brensocatib in Patients with Bronchiectasis: Subgroup Analyses from the WILLOW Trial

James D Chalmers,Michael R Loebinger,Ariel Teper,Pamela J McShane,Carlos Fernandez,Sebastian Fucile,Charles S Haworth,Melanie Lauterio,Roald van der Laan,Vivian H Shih,Mark L Metersky

ERJ open researchno. 1 (2025)

引用0浏览0WOS引用

Insights from the European Nontuberculous Mycobacterial Pulmonary Disease PAtient Disease Experience (ENPADE) Survey– Exploring Disease Burden and Impact

Michal Shteinberg,Marko Obradovic,Roald van der Laan, Christian Hoenig, Roger J. Legtenberg, Andreas L. G. Reimann,Natalie Lorent

BMC Pulmonary Medicineno. 1 (2025): 1-9

引用0浏览0WOS引用

Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews

Christian Hoenig,Roald van der Laan,Andreas Reimann, Marina Hoffmann, Stephan Tyler, Claudia Wiesmann,Marko Obradovic

Advances in Therapyno. 6 (2023): 2915-2926

引用0浏览0WOS引用

The Response

Michael R. Loebinger,Jennifer K. Quint,Roald van der Laan,Marko Obradovic,Rajinder Chawla,Amit Kishore,Jakko van Ingen

CHESTno. 5 (2023): E156-E157

引用0浏览0引用

Dipeptidyl Peptidase-1 Inhibition in Bronchiectasis with Eosinophilic Endotype in the WILLOW Trial

James D. Chalmers,Mark L. Metersky,Ariel Teper,Carlos Fernandez, Sebastian Fucille,Melanie Lauterio,Roald Van Der Laan, Andreas Maes,Michael R. Loebinger

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

Global Survey of Physician Testing Practices for Nontuberculous Mycobacteria

Michael R. Loebinger,Roald van der Laan,Marko Obradovic,Jakko van Ingen

ERJ OPEN RESEARCHno. 3 (2023)

引用1浏览0WOS引用

Patient-reported Burden of Nontuberculous Mycobacterial Lung Disease - Results from a European Patient Survey

Roald van der Laan, Christian Hoening, Roger Legtenberg,Andreas Reimann,Marko Obradovic

EUROPEAN RESPIRATORY JOURNAL（2023）

引用0浏览0引用

EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-1 INHIBITION WITH BRENSOCATIB IN THE FREQUENT EXACERBATOR PHENOTYPE: A SUBGROUP ANALYSIS FROM THE WILLOW TRIAL

Michael Loebinger,Mark L. Metersky,Ariel Teper,Carlos Fernandez,Sebastian Fucile,Melanie Lauterio,Roald van der Laan,Andrea Maes,James D. Chalmers

CHEST Journal（2023）

引用0浏览0引用

Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease

Michael R. Loebinger, Jennifer K. Quint,Roald van der Laan,Marko Obradovic,Rajinder Chawla,Amit Kishore,Jakko van Ingen

CHESTno. 5 (2023): 1115-1124

引用0浏览0引用

Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis

Michael R. Loebinger,Jennifer K. Quint,Roald van der Laan,Marko Obradovic,Rajinder Chawla,Amit Kishore,Jakko van Ingen

CHEST（2023）

引用9浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn